Navigation Links
Alseres Pharmaceuticals, Inc. Receives Notice of Non-Compliance with Continued Listing Requirements
Date:1/12/2009

HOPKINTON, Mass., Jan. 12 /PRNewswire-FirstCall/ -- Alseres Pharmaceuticals, Inc. today announced that on January 8, 2009, it received notice from the NASDAQ Stock Market ("NASDAQ") that for the last 10 consecutive trading days, the market value of its listed securities has been below the minimum $35 million requirement for continued inclusion under NASDAQ Marketplace 4310(c)(3)(B). Furthermore, NASDAQ stated that the Company does not comply with NASDAQ Marketplace Rule 4310(c)(3)(A) or 4310(c)(3)(C), which requires the Company to have either minimum stockholders' equity of $2.5 million or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080813/NEW056LOGO )

In accordance with NASDAQ Marketplace Rule 4310(c)(8)(C), the Company was provided thirty calendar days, or until February 9, 2009 (the "Compliance Period"), to regain compliance. This requires, at a minimum, that the market value of listed securities of the Company's common stock remain $35,000,000 or more for a minimum of 10 consecutive business days at anytime prior to February 9, 2009.

If the Company does not regain compliance within the Compliance Period, NASDAQ will provide the Company with written notification that the Company's common stock will be delisted from the NASDAQ Capital Market. At that time, the Company may appeal the determination by the NASDAQ Staff to delist its common stock to a Listing Qualifications Panel. The Company is currently considering actions that may allow it to regain compliance with the NASDAQ continued listing standards and maintain its NASDAQ listing. There is no assurance that the Company will be able to take any of these actions or that any of the actions will be sufficient to allow the Co
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
2. Alseres Pharmaceuticals, Inc. Raises $5 Million
3. Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K
4. Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference
5. Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call
6. Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results
7. Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)
8. Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
9. Alseres Pharmaceuticals, Inc.s Chairman, Peter Savas, Reviews Companys Progress in its Annual Letter to Stockholders
10. Alseres Pharmaceuticals to Host 2008 Second Quarter Conference Call
11. Alseres Pharmaceuticals, Inc. Reports Second Quarter 2008 Operational and Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)..., PartnershipswithMinorityBanksin Washingto...umbia , S.C. IntendedtoSpurEconomicGrowthandRev...e-USNewswire/--DaVita,thenation,sleadingproviderof...embersoftheAnacostiacommunityfora$1millioninvestme...tinginminoritycommunities. ,, DaVita,sinvestmen...
(Date:11/23/2009)..., SayscuttingMedicaretofinance"reform"isamo...Newswire/--WhiletheSenateDemocratsmovedforwardtobe...nd,RetireSafe,a400,000supporterstronggrassrootssen...ograbtheirbullhornstoprotestthemassivecutstoMedica...ewatchingthefocusshifttoissuesliketaxes,abortion,a...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire-USNewswire/-- ...nation,slargestindividualmembershipassociationofst...resentativeTimScott forpre-filinga constitutionala...ownhealthcarechoices.SouthCarolinanowbecomesthe24t...ce,legislationmodeledafterALEC,s FreedomofChoicein...
(Date:11/23/2009)..., CHERRYHILL,N.J.,Nov.23/PRNewswire/--Inasurv...OfficersandChiefFinancialOfficers,72percentdonotbe...ealthcaresystem. ,, Accordingtoresultsofthelate...yHill,NJaccountingfirm,theeconomytoppedthelistat85...nts129responsestoits1500surveyssenttocompaniesfrom...
(Date:11/23/2009)...bstructive polyps can impair breathing, protein ma...thDay News) -- U.S. researchers say they,ve ident...s in 15 percent to 30 percent of people with chro...st serious forms of sinusitis, a constant irritati...healthy overgrowths of sinus tissue -- can block t...
Breaking Medicine News(10 mins):Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 2Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 3Health News:DaVita Launches Minority Bank Initiative with $1 Million Investment in Industrial Bank of Washington, D.C. to Support Underserved Communities 4Health News:RetireSafe Calls on Seniors to Grab their Bullhorns to Save Medicare from Rationed Care 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2Health News:Research Yields Clues to Severe Form of Sinusitis 2
...on Krohngold, SEATTLE, June 24 iDocLocker, a lea...ords (EMR) systems customized,specifically for sle...n,Krohngold as field sales representative., "Jon ...ld sales representative, he,ll play a crucial role...
..., Inc. (Pink,Sheets: GOHE) announced today that th...M Marketing, based in Myakka, Florida. Under the t... with a number of marketing and,sales related serv...-- Creation of a promotional video, -- Creation o...
...24 Synovics,Pharmaceuticals, Inc. (OTC Bulletin B...oday announced that its wholly owned subsidiary,AN...leading pharmaceutical,company for the manufacturi...pharmaceutical company, are between $7.5,million a...
...une 25th in the open-access journal PLoS Neglecte... similar to those plaguing Africa, Asia, and Latin...oorest people in the United States, especially wom...nfections. , While most Americans have never hea...
...ines address the prevention and management of thro...commendations related to the routine use of preven...une issue of CHEST , the peer-reviewed journal of...ition was developed by an international panel of 9...
...e diagnosis, French researchers say , , TU...ists report they,ve simplified a method of scannin...ntially making it easier to diagnose the mind-robb... a researcher from the Cognitive Neuroscience and ...
Other Medicine News:Health News:Leading Provider of Electronic Medical Records (EMR) Systems for Sleep Centers Adds Field Sales Representative 2Health News:Go Healthy Signs Marketing Contract with AIM Marketing 2Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 2Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 3Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 4Health News:Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract 5Health News:'Neglected infections of poverty' in US disable hundreds of thousands of Americans annually 2Health News:New blood clot guidelines for pregnant women 2Health News:New blood clot guidelines for pregnant women 3Health News:New blood clot guidelines for pregnant women 4Health News:Brain Scans Detect Alzheimer's Disease Quickly 2Health News:Brain Scans Detect Alzheimer's Disease Quickly 3
(Date:11/23/2009)...3/PRNewswire-FirstCall/--Anesiva,Inc.(Nasdaq: ANSV...chardhaveagreedtojointheAnesivaboardofdirectorsfol...ndArcionTherapeutics.Completionofthemergerissubjec...uslyannouncedAnesiva2009AnnualMeetingofStockholder...Point,Suite107A,SouthSanFrancisco,California,among...
(Date:11/23/2009)...e-FirstCall/--RaptorPharmaceuticalCorp.("Raptor"or...ntationofclinicaltrialdataonNGX426,theCompany,sora...agonist,atthe12thInternationalConferenceontheMecha...0-21inSanFrancisco.TheresultsofthestudyledbyMarkWa...enterforPainMedicineoftheUniversityofCaliforniaatS...
(Date:11/23/2009)...ire/--SagentPharmaceuticals,Inc.,aprivately-heldsp...products,todayannouncedthatJefferyM.Yordon,chiefex...tPharmaceuticals,willpresentatthe21stAnnualPiperJa...t9:30ameasterntimeattheNewYorkPalaceHotelinNewYork..., SagentPharmaceuticals,foundedin2006,isaprivat...
Breaking Medicine Technology:Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 2Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 3Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 4Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain 5CancerCare 28R 29 and the Tic Tac 28R 29 Brand Attempt To Set a World Record in Times Square 54830 1CancerCare 28R 29 and the Tic Tac 28R 29 Brand Attempt To Set a World Record in Times Square 54830 2CancerCare 28R 29 and the Tic Tac 28R 29 Brand Attempt To Set a World Record in Times Square 54830 3A UK Cosmetic Surgery First 3A An Eyelash Transplant Procedure 54827 1A UK Cosmetic Surgery First 3A An Eyelash Transplant Procedure 54827 2Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 1Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 2Plasma protein Therapies Association Focuses Attention on Donors and Facilities 54825 3
...axis Treatment with Kogenate FS Reduces the,Risk o...h No Pre-Existing,Joint Damage, BERKELEY, Calif.,...t the U.S. Food and Drug Administration (FDA) has,...ntihemophilic Factor,(Recombinant) to reduce the f...t damage in patients aged 0-16 years with severe h...
...ses on the need to protect the eyesight of,older p... worldwide who,are blind, 80 percent are over age ...their blindness if they had been properly diagnose...e, go to:, http://www.prnewswire.com/mnr/orbis/352...cts and equipment, is,partnering with nonprofit OR...
Other Medicine Technology:FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 2FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 3FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 4FDA Approves Bayer HealthCare's Kogenate(R) FS Treatment for Routine Prophylaxis in Children with Hemophilia A 5ORBIS and Alcon Call Attention to the Aging Eye 2ORBIS and Alcon Call Attention to the Aging Eye 3
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
...tories is a national reference laboratory and a wo...nd development. ARUP offers an extensive test menu...nical and anatomic pathology. Owned by the Univers...re than half of the nation's university teaching h...
Medicine Products: